US · Healthcare

Chugai Pharmaceutical Co Ltd ADR (CHGCY)

Drug Manufacturers - General

Chugai Pharmaceutical Co Ltd ADR (CHGCY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CHGCY

P/E ratio

18.00

Chugai Pharmaceutical Co Ltd ADR (CHGCY) — FAQ

What is CHGCY's P/E ratio?

The price-to-earnings (P/E) ratio for Chugai Pharmaceutical Co Ltd ADR (CHGCY) is 18.00 (data as of 2026-03-23).

Does Chugai Pharmaceutical Co Ltd ADR pay a dividend?

Dividend yield is not available in the current snapshot for Chugai Pharmaceutical Co Ltd ADR (CHGCY). Check the MyAverix Finance app for the latest dividend data.

What sector is Chugai Pharmaceutical Co Ltd ADR in?

Chugai Pharmaceutical Co Ltd ADR (CHGCY) is classified in the Healthcare sector (Drug Manufacturers - General industry).

What exchange is CHGCY listed on?

CHGCY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)